Literature DB >> 19086053

Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.

Mònica Gratacòs1, Javier Costas, Rafael de Cid, Mònica Bayés, Juan R González, Enrique Baca-García, Yolanda de Diego, Fernando Fernández-Aranda, José Fernández-Piqueras, Miriam Guitart, Rocío Martín-Santos, Lourdes Martorell, José M Menchón, Miquel Roca, Jerónimo Sáiz-Ruiz, Julio Sanjuán, Marta Torrens, Mikel Urretavizcaya, Joaquín Valero, Elisabet Vilella, Xavier Estivill, Angel Carracedo.   

Abstract

A fundamental difficulty in human genetics research is the identification of the spectrum of genetic variants that contribute to the susceptibility to common/complex disorders. We tested here the hypothesis that functional genetic variants may confer susceptibility to several related common disorders. We analyzed five main psychiatric diagnostic categories (substance-abuse, anxiety, eating, psychotic, and mood disorders) and two different control groups, representing a total of 3,214 samples, for 748 promoter and non-synonymous single nucleotide polymorphisms (SNPs) at 306 genes involved in neurotransmission and/or neurodevelopment. We identified strong associations to individual disorders, such as growth hormone releasing hormone (GHRH) with anxiety disorders, prolactin regulatory element (PREB) with eating disorders, ionotropic kainate glutamate receptor 5 (GRIK5) with bipolar disorder and several SNPs associated to several disorders, that may represent individual and related disease susceptibility factors. Remarkably, a functional SNP, rs945032, located in the promoter region of the bradykinin receptor B2 gene (BDKRB2) was associated to three disorders (panic disorder, substance abuse, and bipolar disorder), and two additional BDKRB2 SNPs to obsessive-compulsive disorder and major depression, providing evidence for common variants of susceptibility to several related psychiatric disorders. The association of BDKRB2 (odd ratios between 1.65 and 3.06) to several psychiatric disorders supports the view that a common genetic variant could confer susceptibility to clinically related phenotypes, and defines a new functional hint in the pathophysiology of psychiatric diseases. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19086053     DOI: 10.1002/ajmg.b.30902

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  38 in total

Review 1.  Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways.

Authors:  A S Howe; H N Buttenschøn; A Bani-Fatemi; E Maron; T Otowa; A Erhardt; E B Binder; N O Gregersen; O Mors; D P Woldbye; K Domschke; A Reif; J Shlik; S Kõks; Y Kawamura; A Miyashita; R Kuwano; K Tokunaga; H Tanii; J W Smoller; T Sasaki; D Koszycki; V De Luca
Journal:  Mol Psychiatry       Date:  2015-09-22       Impact factor: 15.992

Review 2.  Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.

Authors:  Hongjie Yuan; Chian-Ming Low; Olivia A Moody; Andrew Jenkins; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2015-04-22       Impact factor: 4.436

Review 3.  Massively parallel sequencing: the next big thing in genetic medicine.

Authors:  Tracy Tucker; Marco Marra; Jan M Friedman
Journal:  Am J Hum Genet       Date:  2009-08       Impact factor: 11.025

4.  Decreased gene expression activity as a result of a mutation in the calreticulin gene promoter in a family case of schizoaffective disorder.

Authors:  S Farashi; M Ohadi; S Hosseinkhani; H Darvish; A Mirabzadeh
Journal:  Cogn Neurodyn       Date:  2015-11-27       Impact factor: 5.082

Review 5.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

6.  Polycomb repressive complex 2 epigenomic signature defines age-associated hypermethylation and gene expression changes.

Authors:  Mikhail G Dozmorov
Journal:  Epigenetics       Date:  2015-04-16       Impact factor: 4.528

7.  Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia.

Authors:  Shashwath A Meda; Gualberto Ruaño; Andreas Windemuth; Kasey O'Neil; Clifton Berwise; Sabra M Dunn; Leah E Boccaccio; Balaji Narayanan; Mohan Kocherla; Emma Sprooten; Matcheri S Keshavan; Carol A Tamminga; John A Sweeney; Brett A Clementz; Vince D Calhoun; Godfrey D Pearlson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

8.  Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.

Authors:  Mi-Ryung Han; Gerard D Schellenberg; Li-San Wang
Journal:  BMC Neurol       Date:  2010-10-08       Impact factor: 2.474

9.  A role for neurotransmission and neurodevelopment in attention-deficit/hyperactivity disorder.

Authors:  Tatiana Roman; Luis A Rohde; Mara H Hutz
Journal:  Genome Med       Date:  2009-11-19       Impact factor: 11.117

10.  A genome-wide association study identifies multiple loci associated with mathematics ability and disability.

Authors:  S J Docherty; O S P Davis; Y Kovas; E L Meaburn; P S Dale; S A Petrill; L C Schalkwyk; R Plomin
Journal:  Genes Brain Behav       Date:  2009-11-10       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.